Project Grant 2301063
Award Date
8/1/23
Completion Date
7/31/26
Dollars Obligated
$450K
Federal Agency
Division of Chemistry
Federal Grant Program
47.049
Assistance Type
Project Grant
Place of Performance
Tampa, FL 33612, USA
Similar Awards
The U.S. Defense Health Agency awarded a $1,619,065 Project Grant to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida under the Military Medical Research and Development (CFDA 12.420) federal grant program. The purpose of this 4-year grant, with a performance period from April 2025 to April 2029, is to develop a behavioral intervention for young adults with advanced cancer. As a National Cancer Institute-designated comprehensive cancer center, the...
This federal Project Grant award, valued at $168,500.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research conducted by the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida, to cotarget Type 1 PRMTS and YAP1 in order to combat EGFR-mutant lung adenocarcinoma. The grant period runs from September 1, 2024 to August 31, 2025. The Moffitt Cancer Center is a nonprofit,...
The U.S. Department of Defense's Defense Health Agency awarded a $481,749 Project Grant to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. (Moffitt Cancer Center) under the Military Medical Research and Development program (CFDA 12.420). The grant, effective September 30, 2023 through September 29, 2026, will support research to dissect the spatial molecular architecture of the transformed cutaneous T cell lymphoma tumor microenvironment, with the goal of identifying novel...
The U.S. Department of Defense's Defense Health Agency has awarded a $762,168 Project Grant to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. under the Military Medical Research and Development (CFDA 12.420) program. The grant, with a project period from September 30, 2023 to September 29, 2026, is intended to "DECONVOLUTE KEY BIOLOGICAL DRIVERS THAT DEFINE SUBSETS OF LETHAL PROSTATE CANCER IN AFRICAN AMERICAN MEN." As a leading National Cancer...
The National Cancer Institute (NCI) awarded a $425,772 Project Grant (CFDA 93.393 - Cancer Cause and Prevention Research) to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida. The 2-year grant, starting on July 15, 2024, will fund an epidemiologic study investigating the association between microplastic pollution in bronchoalveolar lavage fluid and lung cancer. The research aims to advance the understanding of environmental factors that may contribute to...
This $328,574 federal Project Grant award, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research by the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. to quantify the spatial properties of immunosuppressive macrophages in papillary renal cell carcinoma. The project aims to advance understanding of immunological mechanisms in kidney cancer, with the goal of developing novel therapeutic approaches....
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $2,837,644 Project Grant to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida. The funding will support "Translational Studies for Targeted Alpha-Particle Therapy for Rare Melanomas" over a 4-year period from September 1, 2023 to August 31, 2027. This project grant aims to advance research into innovative cancer therapies, specifically exploring...
This Project Grant award of $1,221,625.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. to develop novel genetic mouse models for studying the progression and metastasis of uveal melanoma. The award period runs from June 1, 2024 to May 31, 2027. Moffitt Cancer Center is a prominent National Cancer Institute-designated comprehensive cancer center...
The National Institute of Standards and Technology (NIST) awarded a $2,440,000 Project Grant under the Congressionally-Identified Projects program (CFDA 11.617) to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida. The purpose of this grant is to fund the acquisition of high-precision microscopes to image cells deep within 3D tumor models. These microscopes will enable the researchers to detect and measure millions of cells within a single tumor,...
This $844,231 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. (Moffitt Cancer Center) to target the POU2F3 protein in small cell lung cancer. The two-year grant, with a period of performance from July 1, 2024 to June 30, 2026, will enable Moffitt Cancer Center to conduct dual up- and downstream targeting of POU2F3, a...